Extent of lymph node removal during esophageal cancer surgery and survival

Journal of the National Cancer Institute

Volumn 107, Issue 5, 2015, Pages

  Schaaf, Maartje Van Der ^a   Johar, Asif ^a   Wijnhoven, Bas ^b   Lagergren, Pernilla ^a   Lagergren, Jesper ^a,c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SURVIVAL; COHORT ANALYSIS; COMORBIDITY; DISEASE SPECIFIC SURVIVAL; ESOPHAGUS CANCER; ESOPHAGUS RESECTION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPH NODE RATIO; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SURGICAL MORTALITY; ADENOCARCINOMA; CANCER STAGING; CARCINOMA, SQUAMOUS CELL; EPIDEMIOLOGY; ESOPHAGEAL NEOPLASMS; LYMPH NODE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RISK; SURVIVAL; SURVIVAL RATE; SWEDEN;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; SURVIVAL RATE; SWEDEN;

EID: 84928436394     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv043     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Lagergren J, Lagergren P. Oesophageal cancer. BMJ. 2010;341:c6280.
3. Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: An updated meta-analysis. Lancet Oncol. 2011;12(7):681-692.
4. van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366(22):2074-2084.
5. Bogoevski D, Onken F, Koenig A, et al. Is it time for a new TNM classification in esophageal carcinoma? Ann Surg. 2008;247(4):633-641.
6. Kelty CJ, Kennedy CW, Falk GL. Ratio of metastatic lymph nodes to total number of nodes resected is prognostic for survival in esophageal carcinoma. J Thorac Oncol. 2010;5(9):1467-1471.
7. D'Journo XB, Doddoli C, Michelet P, et al. Transthoracic esophagectomy for adenocarcinoma of the oesophagus: standard versus extended two-field mediastinal lymphadenectomy? Eur J Cardiothorac Surg. 2005;27(4):697-704.
8. Hu Y, Hu C, Zhang H, et al. How does the number of resected lymph nodes influence TNM staging and prognosis for esophageal carcinoma? Ann Surg Oncol. 2010;17(3):784-790.
9. Allum WH, Blazeby JM, Griffin SM, et al. Guidelines for the management of oesophageal and gastric cancer. Gut. 2011;60(11):1449-1472.
10. Lagarde SM, Vrouenraets BC, Stassen LP, et al. Evidence-based surgical treatment of esophageal cancer: overview of high-quality studies. Ann Thorac Surg. 2010;89(4):1319-1326.
11. Pennathur A, Gibson MK, Jobe BA, et al. Oesophageal carcinoma. Lancet. 2013;381(9864):400-412.
12. Mariette C, Piessen G, Briez N, et al. Oesophagogastric junction adenocarcinoma: which therapeutic approach? Lancet Oncol. 2011;12(3):296-305.
13. Pultrum BB, Honing J, Smit JK, et al. A critical appraisal of circumferential resection margins in esophageal carcinoma. Ann Surg Oncol. 2010;17(3):812-820.
14. Mulligan ED, Dunne B, Griffin M, et al. Margin involvement and outcome in oesophageal carcinoma: A 10-year experience in a specialist unit. Eur J Surg Oncol. 2004;30(3):313-317.
15. Altorki NK, Zhou XK, Stiles B, et al. Total number of resected lymph nodes predicts survival in esophageal cancer. Ann Surg. 2008;248(2):221-226.
16. Rouvelas I, Zeng W, Lindblad M, et al. Survival after surgery for oesophageal cancer: A population-based study. Lancet Oncol. 2005;6(11):864-870.
17. Derogar M, Sadr-Azodi O, Johar A, et al. Hospital and surgeon volume in relation to survival after esophageal cancer surgery in a population-based study. J Clin Oncol. 2013;31(5):551-557.
18. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825-831.
19. Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: A sample survey for year 1998. Acta Oncol. 2009;48(1):27-33.
20. Lindblad M, Ye W, Lindgren A, et al. Disparities in the classification of esophageal and cardia adenocarcinomas and their influence on reported incidence rates. Ann Surg. 2006;243(4):479-485.
21. Lagergren K, Derogar M. Validation of oesophageal cancer surgery data in the Swedish Patient Registry. Acta Oncol. 2012;51(1):65-68.
22. Sobin LH, Gospodarowicz MK, Wittekind C. UICC TNM Classification of Malignant Tumours, 7th Edition. Wiley-Blackwell; 2009.
23. Pathologists CoA. Protocol for the examination of specimens from patients with carcinoma of the oesophagus. College of American Pathologists (CAP);. In; 2009.
24. Cohen JC, Cohen P. Applied multiple regression/correlation analysis for the behavioral sciences, 2nd edition. Hillsdale, NJ: Lawrence Erlbaum; 1983.
25. Rizk NP, Ishwaran H, Rice TW, et al. Optimum lymphadenectomy for esophageal cancer. Ann Surg. 2010;251(1):46-50.
26. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347(21):1662-1669.
27. Omloo JM, Lagarde SM, Hulscher JB, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial. Ann Surg. 2007;246(6):992-1000; discussion 1000-1001.
28. Davies AR SH, Adeniran A, Mattsson F, et al. Surgical resection strategy and the influence of radicality on outcomes in esophageal cancer-Analysis of 664 consecutive cases of transhiatal and transthoracic oesophagectomies. Br J Surg. 2014;109(5):459-64.
29. Nishihira T, Hirayama K, Mori S. A prospective randomized trial of extended cervical and superior mediastinal lymphadenectomy for carcinoma of the thoracic esophagus. Am J Surg. 1998;175(1):47-51.
30. Fox M, Farmer R, Scoggins CR, et al. Lymph node ratio is a significant predictor of disease-specific mortality in patients undergoing esophagectomy for cancer. Am Surg. 2012;78(5):528-534.
31. Greenstein AJ, Litle VR, Swanson SJ, et al. Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer. Cancer. 2008;112(6):1239-1246.
32. Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17(7):1721-1724.
33. Peyre CG, Hagen JA, DeMeester SR, et al. The number of lymph nodes removed predicts survival in esophageal cancer: An international study on the impact of extent of surgical resection. Ann Surg. 2008;248(4):549-556.
34. Herbella FA, Laurino Neto RM, Allaix ME, Patti MG. Extended lymphadenectomy in esophageal cancer is debatable. World J Surg. 2013;37(8):1757-1767.
35. Wong J, Weber J, Almhanna K, et al. Extent of lymphadenectomy does not predict survival in patients treated with primary esophagectomy. J Gastrointest Surg. 2013;17(9):1562-1568; discussion 1569.
36. Zhang HL, Chen LQ, Liu RL, et al. The number of lymph node metastases influences survival and International Union Against Cancer tumor-node-metastasis classification for esophageal squamous cell carcinoma. Dis Esophagus. 2010;23(1):53-58.
37. Bollschweiler E, Baldus SE, Schroder W, et al. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors? J Surg Oncol. 2006;94(5):355-363.
38. Yam PC, Tong D, Law S. Comparisons of Sixth and Seventh Edition of the American Joint Cancer Committee Staging Systems for Esophageal Cancer. Ann Surg Oncol. 2014;21(2):583-588.
39. Talsma K, van Hagen P, Grotenhuis BA, et al. Comparison of the 6th and 7th Editions of the UICC-AJCC TNM Classification for Esophageal Cancer. Ann Surg Oncol. 2012;19(7):2142-2148.
40. Grotenhuis BA, Wijnhoven BP, van Marion R, et al. The sentinel node concept in adenocarcinomas of the distal esophagus and gastroesophageal junction. J Thorac Cardiovasc Surg. 2009;138(3):608-612.